US$1.9m funding for new technology to help Parkinson’s patients regain mobility

News

Author: AdminPublished: 2 November 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US government’s National Institute of Health has invested almost US$2 million in new technology to improve the effectiveness of deep brain stimulation (DBS) for people with Parkinson’s disease.

The new technology developed by Great Lake NeuroTechnologies (GLNT) will combine wearable motor symptom sensing and the current DBS platform into a single, integrated system and promises to improve patient care and expand access to the treatment.

Dustin Heldman, biomedical research manager at GLNT, said: “We look forward to this next phase, which will directly integrate the systems to improve clinical workflow and speed programming time.”

Go Back

Share this story

Comments


Related articles


Special reports

Are we too focused on the search for a Parkinson’s cure?

We ask Parkinson’s experts for their views on this controversial debate

READ MORE
2 year old with PD lead

Perspectives

Two-year-old could be world’s youngest person diagnosed with Parkinson’s

Toddler diagnosed with juvenile Parkinson’s disease with dystonia

READ MORE
needle-lead

Advances

The huge potential of nanotechnology on new Parkinson’s treatments

Can tiny mesh electronics revolutionise Parkinson’s treatments?

READ MORE